Αποτελέσματα Αναζήτησης
20 Αυγ 2020 · We investigated if blood donations increase the risk of developing hematological malignancies, specifically acute lymphoblastic leukemia, acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), chronic myeloid leukemia, Hodgkin lymphoma, and myeloma, as well other non-Hodgkin lymphoma.
5 Ιουν 2014 · Abstract. We compared serious early and late events experienced by 2726 bone marrow (BM) and 6768 peripheral blood stem cell (PBSC) donors who underwent collection of PBSC or BM between 2004 and 2009 as part of a prospective study through the National Marrow Donor Program.
16 Ιαν 2019 · Increased thrombin production not only increases blood coagulation, but also promotes tumour growth and metastasis and as a consequence, thrombin and its contributors present opportunities for treatment of cancer-associated thrombosis and cancer itself.
16 Απρ 2008 · To investigate possible effects of blood donation and iron loss through blood donation on cancer incidence while minimizing “healthy donor effects,” we made dose–response comparisons within a cohort of Swedish and Danish blood donors.
Abstract. Patients with active cancer are at an increased risk of arterial and venous thromboembolism (VTE) and bleeding events.
8 Μαρ 2022 · Wondering whether to donate whole blood, platelets or double red cells? The best donation may depend on your blood type – and our cancer patients’ needs that day.
17 Σεπ 2020 · Randomized controlled trials that compared a therapeutic dose of a DOAC vs a therapeutic dose of an LMWH (either full dose or full dose followed by reduced dose) in patients with acute symptomatic or incidental VTE and active cancer or a recent history of cancer were eligible.
